ArticleFrontiers in pharmacology2022

Atractylenolide-1 Targets FLT3 to Regulate PI3K/AKT/HIF1-α Pathway to Inhibit Osteogenic Differentiation of Human Valve Interstitial Cells.

Jie Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.